| Type |
Details |
Score |
| Publication |
| First Author: |
Muthalagu N |
| Year: |
2020 |
| Journal: |
Cancer Discov |
| Title: |
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma. |
| Volume: |
10 |
| Issue: |
6 |
| Pages: |
872-887 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yan Y |
| Year: |
2016 |
| Journal: |
Cancer Res |
| Title: |
KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. |
| Volume: |
76 |
| Issue: |
8 |
| Pages: |
2419-31 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zheng X |
| Year: |
2015 |
| Journal: |
Nature |
| Title: |
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. |
| Volume: |
527 |
| Issue: |
7579 |
| Pages: |
525-530 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Garcia Garcia CJ |
| Year: |
2022 |
| Journal: |
Gastroenterology |
| Title: |
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. |
| Volume: |
162 |
| Issue: |
7 |
| Pages: |
2018-2031 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li C |
| Year: |
2018 |
| Journal: |
Dev Cell |
| Title: |
PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. |
| Volume: |
46 |
| Issue: |
4 |
| Pages: |
441-455.e8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Michael IP |
| Year: |
2019 |
| Journal: |
Dev Cell |
| Title: |
ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis. |
| Volume: |
49 |
| Issue: |
3 |
| Pages: |
409-424.e6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Collisson EA |
| Year: |
2012 |
| Journal: |
Cancer Discov |
| Title: |
A central role for RAF?MEK?ERK signaling in the genesis of pancreatic ductal adenocarcinoma. |
| Volume: |
2 |
| Issue: |
8 |
| Pages: |
685-93 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yamaguchi J |
| Year: |
2024 |
| Journal: |
Cancer Med |
| Title: |
Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. |
| Volume: |
13 |
| Issue: |
11 |
| Pages: |
e7395 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nishikawa Y |
| Year: |
2019 |
| Journal: |
Oncogene |
| Title: |
Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis. |
| Volume: |
38 |
| Issue: |
22 |
| Pages: |
4283-4296 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Parajuli P |
| Year: |
2019 |
| Journal: |
EMBO J |
| Title: |
TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma. |
| Volume: |
38 |
| Issue: |
13 |
| Pages: |
e101067 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Antonucci L |
| Year: |
2025 |
| Journal: |
Nat Cancer |
| Title: |
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer. |
| Volume: |
6 |
| Issue: |
7 |
| Pages: |
1263-1282 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Saborowski M |
| Year: |
2014 |
| Journal: |
Genes Dev |
| Title: |
A modular and flexible ESC-based mouse model of pancreatic cancer. |
| Volume: |
28 |
| Issue: |
1 |
| Pages: |
85-97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Elahi-Gedwillo KY |
| Year: |
2019 |
| Journal: |
Cancer Res |
| Title: |
Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma. |
| Volume: |
79 |
| Issue: |
2 |
| Pages: |
372-386 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mart??nez-Bosch N |
| Year: |
2026 |
| Journal: |
Sci Adv |
| Title: |
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity. |
| Volume: |
12 |
| Issue: |
19 |
| Pages: |
eadu8849 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Philip B |
| Year: |
2013 |
| Journal: |
Gastroenterology |
| Title: |
A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. |
| Volume: |
145 |
| Issue: |
6 |
| Pages: |
1449-58 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Krebs AM |
| Year: |
2017 |
| Journal: |
Nat Cell Biol |
| Title: |
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. |
| Volume: |
19 |
| Issue: |
5 |
| Pages: |
518-529 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Valenti G |
| Year: |
2025 |
| Journal: |
Cell Rep |
| Title: |
Regulatory network analysis of Dclk1 gene expression reveals a tuft cell-ILC2 axis that inhibits pancreatic tumor progression. |
| Volume: |
44 |
| Issue: |
6 |
| Pages: |
115734 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mann KM |
| Year: |
2012 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. |
| Volume: |
109 |
| Issue: |
16 |
| Pages: |
5934-41 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sozzi S |
| Year: |
2024 |
| Journal: |
J Exp Clin Cancer Res |
| Title: |
Inactivation of HIPK2 attenuates KRAS(G12D) activity and prevents pancreatic tumorigenesis. |
| Volume: |
43 |
| Issue: |
1 |
| Pages: |
265 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dosch JS |
| Year: |
2015 |
| Journal: |
Cancer Res |
| Title: |
Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer. |
| Volume: |
75 |
| Issue: |
21 |
| Pages: |
4582-92 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Han J |
| Year: |
2026 |
| Journal: |
Nat Cancer |
| Title: |
Spatiotemporal control of SMARCA5 by a MAPK-RUNX1 axis distinguishes mutant KRAS-driven pancreatic malignancy from tissue regeneration. |
| Volume: |
7 |
| Issue: |
1 |
| Pages: |
43-59 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mearns H |
| Year: |
2026 |
| Journal: |
Mol Oncol |
| Title: |
Identification of serum protein biomarkers for pre-cancerous lesions associated with pancreatic ductal adenocarcinoma. |
| Volume: |
20 |
| Issue: |
6 |
| Pages: |
1473-1493 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chen Y |
| Year: |
2022 |
| Journal: |
Cancer Cell |
| Title: |
Oncogenic collagen I homotrimers from cancer cells bind to ?3?1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. |
| Volume: |
40 |
| Issue: |
8 |
| Pages: |
818-834.e9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Astuti Y |
| Year: |
2024 |
| Journal: |
Nat Cancer |
| Title: |
Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. |
| Volume: |
5 |
| Issue: |
5 |
| Pages: |
774-790 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Corsa CAS |
| Year: |
2019 |
| Journal: |
J Biol Chem |
| Title: |
The E3 ubiquitin ligase parkin is dispensable for metabolic homeostasis in murine pancreatic ? cells and adipocytes. |
| Volume: |
294 |
| Issue: |
18 |
| Pages: |
7296-7307 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Unger L |
| Year: |
2026 |
| Journal: |
Genes Dev |
| Title: |
Defective HNF1A hinders GLI3 processing favoring duodenal versus pancreatic fate, thus leading to intestinal elongation in vivo. |
| Volume: |
40 |
| Issue: |
11-12 |
| Pages: |
805-831 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Oropeza D |
| Year: |
2015 |
| Journal: |
Diabetes |
| Title: |
Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone. |
| Volume: |
64 |
| Issue: |
11 |
| Pages: |
3798-807 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Elghazi L |
| Year: |
2008 |
| Journal: |
Genesis |
| Title: |
Generation of a reporter mouse line expressing Akt and EGFP upon Cre-mediated recombination. |
| Volume: |
46 |
| Issue: |
5 |
| Pages: |
256-64 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zheng D |
| Year: |
2024 |
| Journal: |
Life Sci Alliance |
| Title: |
Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo. |
| Volume: |
7 |
| Issue: |
7 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Luo C |
| Year: |
2026 |
| Journal: |
Life Sci Alliance |
| Title: |
SOX2 is a dispensable modulator of NUT carcinoma oncogenesis in mice. |
| Volume: |
9 |
| Issue: |
2 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zalucha EM |
| Year: |
2026 |
| Journal: |
Cells |
| Title: |
The Role of Pancreatic Preproglucagon in Regulating Local Inflammation in Mice. |
| Volume: |
15 |
| Issue: |
5 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim KS |
| Year: |
2019 |
| Journal: |
JCI Insight |
| Title: |
Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy. |
| Volume: |
4 |
| Issue: |
20 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cigliola V |
| Year: |
2018 |
| Journal: |
Nat Cell Biol |
| Title: |
Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon(+) ?-cells. |
| Volume: |
20 |
| Issue: |
11 |
| Pages: |
1267-1277 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang L |
| Year: |
2025 |
| Journal: |
Sci Adv |
| Title: |
The expression order determines the pioneer functions of NGN3 and NEUROD1 in pancreatic endocrine differentiation. |
| Volume: |
11 |
| Issue: |
13 |
| Pages: |
eadt4770 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim ER |
| Year: |
2015 |
| Journal: |
J Neurosci |
| Title: |
Hypothalamic Non-AgRP, Non-POMC GABAergic Neurons Are Required for Postweaning Feeding and NPY Hyperphagia. |
| Volume: |
35 |
| Issue: |
29 |
| Pages: |
10440-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wasylishen AR |
| Year: |
2020 |
| Journal: |
Sci Adv |
| Title: |
Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo. |
| Volume: |
6 |
| Issue: |
32 |
| Pages: |
eaba8415 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Luo C |
| Year: |
2025 |
| Journal: |
Adv Sci (Weinh) |
| Title: |
Deficiency of Leucine-Rich Repeat Containing G Protein-Coupled Receptor 4 in Pancreas Reduces ? Cell Mass. |
| Volume: |
12 |
| Issue: |
41 |
| Pages: |
e08858 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lorberbaum DS |
| Year: |
2020 |
| Journal: |
Development |
| Title: |
Retinoic acid signaling within pancreatic endocrine progenitors regulates mouse and human ? cell specification. |
| Volume: |
147 |
| Issue: |
12 |
|
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Hmga2/Hmga2<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+> |
| Background: |
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd9/Cd9<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53 |
| Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd9/Cd9 Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+> |
| Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd9/Cd9 Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53 |
| Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd9/Cd9<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)6Tuv/? Trp53/Trp53<+> |
| Background: |
involves: 129P2/OlaHsd * 129S4/SvJae * 129X1/SvJ * C57BL/6N * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/? Trim29/Trim29 Trp53/Trp53<+> |
| Background: |
involves: 129 * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/? Trim29/Trim29 |
| Background: |
involves: 129 * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Kras/Kras<+> Tg(Pdx1-cre)89.1Dam/? Trim29/Trim29<+> Trp53/Trp53<+> |
| Background: |
involves: 129 * C57BL/6 * CBA |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gata4/Gata4<+> Gata6/Gata6<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)6Tuv/? |
| Background: |
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gata4/Gata4 Gata6/Gata6 Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)6Tuv/? |
| Background: |
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gata4/Gata4<+> Gata6/Gata6<+> Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)6Tuv/? |
| Background: |
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gata4/Gata4 Gata6/Gata6 Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Pdx1-cre)6Tuv/? |
| Background: |
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * FVB/N |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor Tg(Pdx1-flpo)#Ybi/? |
| Background: |
involves: 129S4/SvJaeSor * 129S6/SvEvTac |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Baumel-Alterzon S |
| Year: |
2024 |
| Journal: |
Diabetologia |
| Title: |
NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function. |
| Volume: |
67 |
| Issue: |
3 |
| Pages: |
547-560 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
559
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
642
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
652
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
505
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
501
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
505
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
652
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
640
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Marcheva B |
| Year: |
2010 |
| Journal: |
Nature |
| Title: |
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. |
| Volume: |
466 |
| Issue: |
7306 |
| Pages: |
627-31 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pasek RC |
| Year: |
2013 |
| Journal: |
Am J Physiol Endocrinol Metab |
| Title: |
Advancements and challenges in generating accurate animal models of gestational diabetes mellitus. |
| Volume: |
305 |
| Issue: |
11 |
| Pages: |
E1327-38 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yu V |
| Year: |
2024 |
| Journal: |
Diabetologia |
| Title: |
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity. |
| Volume: |
67 |
| Issue: |
6 |
| Pages: |
1079-1094 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Collier JJ |
| Year: |
2021 |
| Journal: |
Mol Metab |
| Title: |
Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis. |
| Volume: |
44 |
|
| Pages: |
101140 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ferreira RMM |
| Year: |
2017 |
| Journal: |
Cell Rep |
| Title: |
Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression. |
| Volume: |
21 |
| Issue: |
4 |
| Pages: |
966-978 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Marquard J |
| Year: |
2015 |
| Journal: |
Nat Med |
| Title: |
Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. |
| Volume: |
21 |
| Issue: |
4 |
| Pages: |
363-72 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Maruno T |
| Year: |
2021 |
| Journal: |
Elife |
| Title: |
Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. |
| Volume: |
10 |
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Todoric J |
| Year: |
2017 |
| Journal: |
Cancer Cell |
| Title: |
Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. |
| Volume: |
32 |
| Issue: |
6 |
| Pages: |
824-839.e8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ma Y |
| Year: |
2024 |
| Journal: |
iScience |
| Title: |
Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. |
| Volume: |
27 |
| Issue: |
11 |
| Pages: |
111085 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Arneson-Wissink PC |
| Year: |
2024 |
| Journal: |
J Cachexia Sarcopenia Muscle |
| Title: |
Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis. |
| Volume: |
15 |
| Issue: |
3 |
| Pages: |
975-988 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee JW |
| Year: |
2019 |
| Journal: |
Nature |
| Title: |
Hepatocytes direct the formation of a pro-metastatic niche in the liver. |
| Volume: |
567 |
| Issue: |
7747 |
| Pages: |
249-252 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ruess DA |
| Year: |
2018 |
| Journal: |
Nat Med |
| Title: |
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. |
| Volume: |
24 |
| Issue: |
7 |
| Pages: |
954-960 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Daley D |
| Year: |
2016 |
| Journal: |
Cell |
| Title: |
?? T Cells Support Pancreatic Oncogenesis by Restraining ?? T Cell Activation. |
| Volume: |
166 |
| Issue: |
6 |
| Pages: |
1485-1499.e15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang G |
| Year: |
2017 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
p53 pathway is involved in cell competition during mouse embryogenesis. |
| Volume: |
114 |
| Issue: |
3 |
| Pages: |
498-503 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ruiz CF |
| Year: |
2026 |
| Journal: |
Cancer Discov |
| Title: |
Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas. |
|
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hruban RH |
| Year: |
2006 |
| Journal: |
Cancer Res |
| Title: |
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. |
| Volume: |
66 |
| Issue: |
1 |
| Pages: |
95-106 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Maddocks ODK |
| Year: |
2017 |
| Journal: |
Nature |
| Title: |
Modulating the therapeutic response of tumours to dietary serine and glycine starvation. |
| Volume: |
544 |
| Issue: |
7650 |
| Pages: |
372-376 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hetzel S |
| Year: |
2025 |
| Journal: |
Genome Biol |
| Title: |
Direct genetic transformation bypasses tumor-associated DNA methylation alterations. |
| Volume: |
26 |
| Issue: |
1 |
| Pages: |
212 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
O'Connor MN |
| Year: |
2021 |
| Journal: |
Med |
| Title: |
LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency. |
| Volume: |
2 |
| Issue: |
11 |
| Pages: |
1231-1252.e10 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang L |
| Year: |
2019 |
| Journal: |
Genes Dev |
| Title: |
ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. |
| Volume: |
33 |
| Issue: |
11-12 |
| Pages: |
641-655 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Poulin EJ |
| Year: |
2019 |
| Journal: |
Cancer Discov |
| Title: |
Tissue-Specific Oncogenic Activity of KRAS(A146T). |
| Volume: |
9 |
| Issue: |
6 |
| Pages: |
738-755 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tomi? G |
| Year: |
2024 |
| Journal: |
Cell Rep |
| Title: |
Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis. |
| Volume: |
43 |
| Issue: |
5 |
| Pages: |
114224 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Perkail S |
| Year: |
2020 |
| Journal: |
Nat Commun |
| Title: |
BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. |
| Volume: |
11 |
| Issue: |
1 |
| Pages: |
3018 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tsuyama T |
| Year: |
2023 |
| Journal: |
EMBO Rep |
| Title: |
Hypoxia causes pancreatic ?-cell dysfunction and impairs insulin secretion by activating the transcriptional repressor BHLHE40. |
| Volume: |
24 |
| Issue: |
8 |
| Pages: |
e56227 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim I |
| Year: |
2009 |
| Journal: |
J Am Soc Nephrol |
| Title: |
Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin. |
| Volume: |
20 |
| Issue: |
12 |
| Pages: |
2556-69 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lin WC |
| Year: |
2013 |
| Journal: |
Cancer Res |
| Title: |
Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. |
| Volume: |
73 |
| Issue: |
6 |
| Pages: |
1821-30 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kopinke D |
| Year: |
2011 |
| Journal: |
Development |
| Title: |
Lineage tracing reveals the dynamic contribution of Hes1+ cells to the developing and adult pancreas. |
| Volume: |
138 |
| Issue: |
3 |
| Pages: |
431-41 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Morris JP 4th |
| Year: |
2010 |
| Journal: |
J Clin Invest |
| Title: |
Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. |
| Volume: |
120 |
| Issue: |
2 |
| Pages: |
508-20 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang Y |
| Year: |
2024 |
| Journal: |
J Hepatol |
| Title: |
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice. |
| Volume: |
81 |
| Issue: |
1 |
| Pages: |
120-134 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bednar F |
| Year: |
2015 |
| Journal: |
Carcinogenesis |
| Title: |
Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. |
| Volume: |
36 |
| Issue: |
7 |
| Pages: |
730-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shi Y |
| Year: |
2019 |
| Journal: |
Nature |
| Title: |
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. |
| Volume: |
569 |
| Issue: |
7754 |
| Pages: |
131-135 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fox RG |
| Year: |
2016 |
| Journal: |
Nature |
| Title: |
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. |
| Volume: |
534 |
| Issue: |
7607 |
| Pages: |
407-411 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rath N |
| Year: |
2017 |
| Journal: |
EMBO Mol Med |
| Title: |
ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. |
| Volume: |
9 |
| Issue: |
2 |
| Pages: |
198-218 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mahadevan KK |
| Year: |
2023 |
| Journal: |
Dev Cell |
| Title: |
Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8(+) T?cells. |
| Volume: |
58 |
| Issue: |
17 |
| Pages: |
1562-1577.e8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nelson JK |
| Year: |
2022 |
| Journal: |
Nat Commun |
| Title: |
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. |
| Volume: |
13 |
| Issue: |
1 |
| Pages: |
2070 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sodir NM |
| Year: |
2022 |
| Journal: |
Nat Commun |
| Title: |
Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution. |
| Volume: |
13 |
| Issue: |
1 |
| Pages: |
6782 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cheung PF |
| Year: |
2018 |
| Journal: |
Cancer Res |
| Title: |
Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting. |
| Volume: |
78 |
| Issue: |
17 |
| Pages: |
4997-5010 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rangel-Sosa MM |
| Year: |
2024 |
| Journal: |
Glia |
| Title: |
Pancreatic Schwann cell reprogramming supports cancer-associated neuronal remodeling. |
| Volume: |
72 |
| Issue: |
10 |
| Pages: |
1840-1861 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Talbert EE |
| Year: |
2019 |
| Journal: |
Cell Rep |
| Title: |
Modeling Human Cancer-induced Cachexia. |
| Volume: |
28 |
| Issue: |
6 |
| Pages: |
1612-1622.e4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dow LE |
| Year: |
2014 |
| Journal: |
PLoS One |
| Title: |
Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice. |
| Volume: |
9 |
| Issue: |
4 |
| Pages: |
e95236 |
|
•
•
•
•
•
|